Multimodal Prehabilitation for Resectable Gastric Cancer

Status Recruiting

Clinical Trial Summary

Surgical resection is the mainstay for gastric cancer. Surgical stress response, like insulin resistance and catabolism, is inevitable and is a risk factor for postoperative outcome. To cope with this stress, the enhanced recovery protocol has been proposed and successfully implemented in clinical practice. Recently, prehabilitation have attracted increasingly attention, which is the preoperative part of enhanced recovery pathway. Prehabtilitation are bundles of evidenced elements in order to improve patient's functional capacity. Patients with gastric cancer are usually suffered from nutritional risk, anxiety and frailty. In this trial, we investigate whether multimodal prehabilitation (exercise, nutrition and psychological support) could improve patient's functional status to better tolerate surgical trauma.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05714878
Study type	Interventional
Source	Chinese PLA General Hospital
Contact	Kecheng Zhang, PhD
Phone	010-66938328
Email	zhangkecheng@301hospital.com.cn
Status	Recruiting
Phase	N/A
Start date	March 22, 2023
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03313700` - Clinical Outcomes of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer	N/A
Recruiting	`NCT05645198` - The Effect of Carboxymetyl Starch (Oozfix) on Preventing Postoperative Complication After Gastrectomy	Phase 4
Completed	`NCT03549494` - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction	Phase 2
Completed	`NCT00935779` - Ultra Structure Of Peritoneum At Electronic Microscopy In Control Subjects And Patients With Gastric Cancer	N/A
Completed	`NCT00144378` - Irinotecan Versus Only Best Supportive Care for Gastric Cancer	Phase 3
Completed	`NCT00290966` - Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer	Phase 2/Phase 3
Recruiting	`NCT03348150` - Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.	Phase 3
Not yet recruiting	`NCT06085677` - The Gastric HormonE BioMarkers of Preneoplastic Lesions Study
Recruiting	`NCT02969122` - Treatment Strategy for Stage IV Gastric Cancer With Positive Peritoneal Cytology as the Only Non-curable Factor	N/A
Completed	`NCT01482299` - RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression	Phase 2
Active, not recruiting	`NCT03760822` - Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients	Phase 2
Recruiting	`NCT00509964` - Second-Line Irinotecan vs. ILF for AGC	Phase 2
Completed	`NCT04889859` - Impact of Biliopancreatic Limb Length on Diabetes Following Distal Gastrectomy	N/A
Completed	`NCT03071237` - The Origin of Infrapyloric Artery
Recruiting	`NCT05184803` - A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer	Phase 2
Completed	`NCT00142038` - Docetaxel and Capecitabine in Advanced Gastric Cancer	Phase 2
Not yet recruiting	`NCT04056260` - ICG-NIR Guided Lymph Node Dissection in Gastric Cancer	N/A
Recruiting	`NCT03065257` - Endoscopic Resection Multicenter Registry	N/A
Recruiting	`NCT04744649` - Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial	Phase 2
Recruiting	`NCT05640609` - Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer	Phase 1/Phase 2